Journal
JOURNAL OF GASTROENTEROLOGY
Volume 58, Issue 4, Pages 379-393Publisher
SPRINGER JAPAN KK
DOI: 10.1007/s00535-023-01959-y
Keywords
Organoids transplantation; Epithelial design; Ulcerative colitis
Categories
Ask authors/readers for more resources
This study focused on the role of sulfomucin in ulcerative colitis (UC) and found that sulfomucin production decreased in the inflammatory region of UC and increased in the distal colon and cecum of mice. Through organoids transplantation, sulfomucin secretion was restored in severely injured distal colon. This study provides a basis for the advancement of organoids transplantation therapy for refractory UC.
BackgroundThe organoids therapy for ulcerative colitis (UC) is under development. It is important to dissect how the engrafted epithelium can provide benefits for overcoming the vulnerability to inflammation. We mainly focused on the deliverability of sulfomucin, which is reported to play an important role in epithelial function.MethodsWe analyzed each segment of colon epithelium to determine differences in sulfomucin production in both mice and human. Subsequently, we transplanted organoids established from sulfomucin-enriched region into the injured recipient epithelium following dextran sulfate sodium-induced colitis and analyzed the engrafted epithelium in mouse model.ResultsIn human normal colon, sulfomucin production was increased in proximal colon, whereas it was decreased in the inflammatory region of UC. In murine colon epithelium, increased sulfomucin production was found in cecum compared to distal small intestine and proximal colon. RNA sequencing analysis revealed that several key genes associated with sulfomucin production such as Papss2 and Slc26a1 were enriched in isolated murine cecum crypts. Then we established murine cecum organoids and transplanted them into the injured epithelium of distal colon. Although the expression of sulfomucin was temporally decreased in cecum organoids, its secretion was restored again in the engrafted patches after transplantation. Finally, we verified a part of mechanisms controlling sulfomucin production in human samples.ConclusionThis study illustrated the deliverability of sulfomucin in the disease-relevant grafting model to design sulfomucin-producing epithelial units in severely injured distal colon. The current study is the basis for the better promotion of organoids transplantation therapy for refractory UC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available